Feed XBRAF
XB

Xebra Brands Ltd.

XBRAF · OTC

$0.00 +0.00% (+$0.00)
1M -99.00%
Market Cap $2.16K
P/E Ratio -
Div. Yield -
ROE 2,092.28%
Piotroski F-Score Weak
1/9
Valuation
100 /100
Cheap
P/B 0.04x
PEG N/A
P/E N/A
Growth
-
N/A
FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A
Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
40 /100
Average
ROA 455.46%
ROIC 666.54%
Asset turnover 0.00x
Debt
68 /100
Low
Current ratio 0.46x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
19 /100
Unstable
Profitable years 0
Beta -3.09x
EPS volatility 173.23%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about XBRAF
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Rodrigo Valencia Gallardo

Employees

2

Headquarters

Vancouver

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.